← Back to Clinical Trials
Recruiting NCT07761845

NCT07761845 Red Cell Distribution Width/Albumin Ratio as a Predictive Tool for Mortality of Patients With Burn Injuries

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07761845
Status Recruiting
Phase
Sponsor Ain Shams University
Condition Burn Injuries
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2026-08-01
Primary Completion 2027-02-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2026-08-01 with a primary completion date of 2027-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to evaluate the prognostic utility of the red cell distribution width/albumin ratio (RAR), measured within 24 hours of hospital admission, in predicting 30-day mortality among patients with burn injuries.

Eligibility Criteria

Inclusion Criteria: * Age \> 18 years. * Both sexes. * Patients with burn injuries (%TBSA \>20%). * Availability of complete laboratory data (RDW, albumin) on admission. * Admission to ICU within 24 hours of burn injury. Exclusion Criteria: * Age \<18 years. * Patients with chronic hematologic disease. * Pre-existing liver disease. * Nephrotic syndrome. * patients on chemotherapy. * Patients with incomplete or missing lab records. * Pregnant females. * Patient or guardian refusal.

Contact & Investigator

Central Contact

Ahlam M abdelnaby. study principal investigator, MBBCH, MSc .

✉ g19-29502090100101@med.asu.edu.eg

📞 +201120327604

Principal Investigator

Adel M Fahmy Shenouda, MD

STUDY CHAIR

Department of Anesthesia, Intensive care and pain management, Faculty of Medicine, Ain Shams University

Frequently Asked Questions

Who can join the NCT07761845 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Burn Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07761845 currently recruiting?

Yes, NCT07761845 is actively recruiting participants. Contact the research team at g19-29502090100101@med.asu.edu.eg for enrollment information.

Where is the NCT07761845 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07761845 clinical trial?

NCT07761845 is sponsored by Ain Shams University. The principal investigator is Adel M Fahmy Shenouda, MD at Department of Anesthesia, Intensive care and pain management, Faculty of Medicine, Ain Shams University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology